PRECIGEN, INC. Goodwill, Foreign Currency Translation Gain (Loss)
PRECIGEN, INC. (PGEN) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$64.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-03-25
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-09-30 was $0.00.
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-06-30 was -$7.00K.
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2024-03-31 was -$57.00K, a 232.56% decline year-over-year.
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$64.00K, a 181.01% decline from fiscal 2023.
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $79.00K.
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$149.00K.
- PRECIGEN, INC. goodwill, foreign currency translation gain (loss) for fiscal 2021 was -$215.00K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | -$7.00K derived: sum of 3 quarters · filed 2026-03-25 | -$64.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$7.00K derived: sum of 2 quarters · filed 2024-11-14 | -$64.00K 10-Q · filed 2024-11-14 | $44.00K derived: sum of 4 quarters · filed 2025-03-19 | |
| 2024-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$64.00K 10-Q · filed 2024-08-14 | $44.00K derived: sum of 3 quarters · filed 2025-03-19 | -$28.00K derived: sum of 4 quarters · filed 2025-03-19 | |
| 2024-03-31 | -$57.00K 10-Q · filed 2024-05-14 | $51.00K derived: sum of 2 quarters · filed 2025-03-19 | -$21.00K derived: sum of 3 quarters · filed 2025-03-19 | -$21.00K derived: sum of 4 quarters · filed 2025-03-19 | |
| 2023-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $36.00K derived: sum of 2 quarters · filed 2025-03-19 | $36.00K derived: sum of 3 quarters · filed 2025-03-19 | $79.00K 10-K · filed 2025-03-19 | |
| 2023-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$72.00K derived: sum of 2 quarters · filed 2023-11-09 | -$29.00K 10-Q · filed 2023-11-09 | $181.00K derived: sum of 4 quarters · filed 2024-03-19 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $43.00K 10-Q · filed 2023-08-09 | $253.00K derived: sum of 3 quarters · filed 2024-03-19 | $102.00K derived: sum of 4 quarters · filed 2024-03-19 | |
| 2023-03-31 | $43.00K 10-Q · filed 2023-05-10 | $253.00K derived: sum of 2 quarters · filed 2024-03-19 | $102.00K derived: sum of 3 quarters · filed 2024-03-19 | -$53.00K derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $59.00K derived: sum of 2 quarters · filed 2024-03-19 | -$96.00K derived: sum of 3 quarters · filed 2024-03-19 | -$149.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | -$151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$306.00K derived: sum of 2 quarters · filed 2022-11-09 | -$359.00K 10-Q · filed 2022-11-09 | -$417.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2022-06-30 | -$155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$208.00K 10-Q · filed 2022-08-08 | -$266.00K derived: sum of 3 quarters · filed 2023-03-06 | -$333.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2022-03-31 | -$53.00K 10-Q · filed 2022-05-09 | -$111.00K derived: sum of 2 quarters · filed 2023-03-06 | -$178.00K derived: sum of 3 quarters · filed 2023-03-06 | -$143.00K derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-12-31 | -$58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$125.00K derived: sum of 2 quarters · filed 2023-03-06 | -$90.00K derived: sum of 3 quarters · filed 2023-03-06 | -$215.00K 10-K · filed 2023-03-06 | |
| 2021-09-30 | -$67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$32.00K derived: sum of 2 quarters · filed 2021-11-08 | -$157.00K 10-Q · filed 2021-11-08 | ||
| 2021-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$90.00K 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | -$125.00K 10-Q · filed 2021-05-10 | ||||
| 2020-09-30 | $115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $169.00K derived: sum of 2 quarters · filed 2020-11-09 | $118.00K 10-Q · filed 2020-11-09 | $1.52M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2020-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.00K 10-Q · filed 2020-08-10 | $1.41M derived: sum of 3 quarters · filed 2020-08-10 | -$381.00K derived: sum of 4 quarters · filed 2020-08-10 | |
| 2020-03-31 | -$51.00K 10-Q · filed 2020-05-11 | $1.35M derived: sum of 2 quarters · filed 2020-05-11 | -$435.00K derived: sum of 3 quarters · filed 2020-05-11 | -$1.27M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$384.00K derived: sum of 2 quarters · filed 2020-03-02 | -$1.22M derived: sum of 3 quarters · filed 2020-03-02 | -$53.00K 10-K · filed 2020-03-02 | |
| 2019-09-30 | -$1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$2.63M derived: sum of 2 quarters · filed 2019-11-12 | -$1.46M 10-Q · filed 2019-11-12 | $431.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-06-30 | -$839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $331.00K 10-Q · filed 2019-08-09 | $2.22M derived: sum of 3 quarters · filed 2020-03-02 | $1.83M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2019-03-31 | $1.17M 10-Q · filed 2019-05-09 | $3.06M derived: sum of 2 quarters · filed 2020-03-02 | $2.67M derived: sum of 3 quarters · filed 2020-03-02 | -$413.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.50M derived: sum of 2 quarters · filed 2020-03-02 | -$1.58M derived: sum of 3 quarters · filed 2020-03-02 | -$124.00K 10-K · filed 2020-03-02 | -$3.70M 10-K · filed 2019-03-01 |
| 2018-09-30 | -$390.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$3.47M derived: sum of 2 quarters · filed 2018-11-08 | -$2.01M 10-Q · filed 2018-11-08 | -$1.72M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2018-06-30 | -$3.08M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | -$1.62M 10-Q · filed 2018-08-13 | -$1.33M derived: sum of 3 quarters · filed 2019-03-01 | $558.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2018-03-31 | $1.46M 10-Q/A · filed 2018-08-13 | $1.75M derived: sum of 2 quarters · filed 2019-03-01 | $3.64M derived: sum of 3 quarters · filed 2019-03-01 | $5.90M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.18M derived: sum of 2 quarters · filed 2019-03-01 | $4.44M derived: sum of 3 quarters · filed 2019-03-01 | $5.09M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $4.15M derived: sum of 2 quarters · filed 2017-11-09 | $4.80M 10-Q · filed 2017-11-09 | $2.18M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2017-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.91M 10-Q · filed 2017-08-09 | $288.00K derived: sum of 3 quarters · filed 2018-03-01 | -$1.18M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2017-03-31 | $650.00K 10-Q · filed 2017-05-10 | -$1.97M derived: sum of 2 quarters · filed 2018-03-01 | -$3.43M derived: sum of 3 quarters · filed 2018-03-01 | -$6.75M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$4.08M derived: sum of 2 quarters · filed 2018-03-01 | -$7.40M derived: sum of 3 quarters · filed 2018-03-01 | -$7.99M 10-K · filed 2018-03-01 | |
| 2016-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$4.78M derived: sum of 2 quarters · filed 2016-11-09 | -$5.38M 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | -$3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$3.91M 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | -$594.00K 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | -$3.29M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |